Triple-Negative Breast Cancer Research and Education Act of 2025

# Triple-Negative Breast Cancer Research and Education Act of 2025 **What the Bill Would Do** This bill aims to increase research funding and public awareness efforts focused on triple-negative breast cancer (TNBC), a particularly aggressive form of breast cancer that is harder to treat than other types. The legislation would direct resources toward studying this disease and educating patients, healthcare providers, and the general public about TNBC. Triple-negative breast cancer represents a smaller percentage of all breast cancers but has worse outcomes and survival rates compared to other breast cancer subtypes, making it a priority for targeted research efforts. **Who It Affects and Current Status** The bill would primarily benefit breast cancer patients—particularly those diagnosed with triple-negative breast cancer—as well as researchers, medical institutions, and healthcare providers involved in cancer treatment and research.

It could also affect federal agencies responsible for distributing research grants, like the National Institutes of Health. As of now, the bill is in committee, meaning it has been introduced but hasn't yet been debated or voted on by the full House of Representatives. The bill was sponsored by Representative Joseph Morelle, a Democrat from New York.